Search Results
Results found for "Dopamine receptor D3"
- Addex's strategic partner The Janssen Pharmaceutical Companies of Johnson & Johnson, Inc. has...
ADX71149 is a selective metabotropic glutamate type 2 (mGlu2) receptor positive allosteric modulator
- GPCR Happy Hour Boston 2026 — April 29 | Dr. GPCR Community Event
It's not a corporate reception. Their deorphanisation track record (17 identified natural receptor-ligand pairs) speaks to the depth
- Enhanced membrane binding of oncogenic G protein αqQ209L confers resistance to inhibitor YM-254890
October 2022 "Heterotrimeric G proteins couple activated G protein-coupled receptors (GPCR) to intracellular
- Biphasic activation of β-arrestin 1 upon interaction with a GPCR revealed by methyl-TROSY NMR
β-arrestins (βarrs) play multifaceted roles in the function of G protein-coupled receptors (GPCRs). βarrs
- Latrophilin-1 drives neuron morphogenesis and shapes chemo- and mechanosensation-dependent ...
in the nematode Caenorhabditis elegans can also function independently of their seven-transmembrane domain specific LAT-1-positive neurons and first insights into the genetic network that is modulated by the receptor
- GPR3 expression in retinal ganglion cells contributes to neuron survival and accelerates axonal...
G protein-coupled receptor 3 (GPR3) belongs to the class A rhodopsin-type GPCR family and is highly expressed
- Inside the New Dr. GPCR Ecosystem: Learning, Insight, and Momentum for 2026
Terry Kenakin ; GIP receptor agonist patent WO2025264700. 🔍 This Week in Dr.GPCR Premium: Sneak Peek
- Applications of Cryo-EM in small molecule and biologics drug design
crystallography, by cryo-EM has enabled insights into important drug target families such as G protein-coupled receptors
- HDX-MS-optimized approach to characterize nanobodies as tools for biochemical and structural ...
in multiple immune signaling processes and is dependent on activation by Ras and G protein-coupled receptors
- A Model for the Signal Initiation Complex Between Arrestin-3 and the Src Family Kinase Fgr
Arrestins regulate a wide range of signaling events, most notably when bound to active G protein-coupled receptors demonstrate using NMR spectroscopy that a polyproline motif within arrestin-3 interacts directly with the SH3 domain To provide a framework for this interaction, we determined the crystal structure of the Fgr SH3 domain
- Allosteric Binding Demystified: Smarter GPCR Drug Discovery
of what’s inside this week’s Premium Edition: Industry insights:  Metabolic GPCRs in the spotlight; receptor Premium delivers clarity where noise dominates. Â
- Early Safety Assays: Identifying Showstoppers in GPCR Drug Discovery Pipelines Early
Screening Compounds are systematically challenged in vitro against a spectrum of cellular targets—enzymes, receptors
- Platelets in the NETworks interweaving inflammation and thrombosis
The surface expression of pattern recognition receptors, such as TLR2 and TLR4, provides platelets with
- Irreversible Drugs, Real Control: Design for Durable Target Engagement
this week:  nanomedicines targeting PAR2 for sustained analgesia; Emerging Voices in GPCR Biology; Domain Must-read publications:  AT1R β-arrestin bias; UII receptor structure; β2AR constant-pH dynamics.
- Structural dynamics of Smoothened (SMO) in ciliary membrane and its interaction with membrane lipids
September 2022 "The Smoothened receptor (SMO, a 7 pass transmembrane domain, Class F GPCR family protein In the absence of HH signaling, SMO is inhibited by Patched 1 (PTC1; a 12 pass transmembrane domain protein We are able to identify the interaction of membrane cholesterols with definite sites and domains within domain (CRD) and the intracellular domain (ICD), are through residues belonging to known cholesterol-binding Structural analysis of SMO domains shows significant changes in the CRD and ICD, during the course of
- Better GPCR Drug Discovery Decisions Start With Structured Learning
Must-read publications: D2 receptor constitutively active mutants; β2AR allosteric SERS assay; CXCR4
- Why Mastering Pharmacokinetics Fundamentals Still Defines Discovery Success Today
PK errors no longer dominate failure statistics, but fundamental blind spots still derail programs Passive diffusion dominates for many small molecules, but protein binding, transporters, and tissue architecture Even perfect receptor pharmacology fails if target-site exposure is insufficient or transient .
- Chemical signaling regulates axon regeneration via the GPCR-Gqα pathway in Caenorhabditis elegans
We demonstrate that the chemoreceptor genes, srg-36 and srg-37, which encode G protein-coupled receptors
- Assay Volume Control: Your GPCR Drug Discovery Power Lever
– Assay Volume Control in GPCR Drug Discovery This week in Terry’s Corner, you’ll learn how dialing receptor
- Deficiency of β-arrestin2 alleviates apoptosis through GRP78-ATF6-CHOP signaling pathway in ...
β-arrestin2 is a key protein that mediates desensitization and internalization of G protein-coupled receptors
- Neuronal Gα subunits required for the control of response to polystyrene nanoparticles in the ...
The aim of this study was to identify Gα proteins mediating function of neuronal G protein-coupled receptors
- Mechanism vs. Assumption: A Model-First Path to Getting GPCR MoA Right
Physiological relevance:  Fluorescent ligands can retain receptor integrity—critical when signaling readouts
- From Snapshots to Predictions: Why Mechanism of Action Matters
What happens when receptor expression is different? What happens in vivo?
- Exendin-4 Attenuates Remodeling in the Remote Myocardium of Rats After an Acute Myocardial ...
Exendin-4, and possibly through G protein-coupled receptors (GPCRs), increases levels of cAMP and upregulates
- Adhesion GPCR Consortium Newsletter - May 2024
BAI1 is expressed in the afferent spiral ganglion neurons in the mouse cochlea where it localizes AMPA receptors
- How to Design GPCR Drugs That Work in Vivo: Strategy, Tools, and Insights
Here’s what Premium Members accessed this week  across four critical domains: Industry insights:  Neurocrine Dual-label specificity blocks promiscuous ligand confusion Lanthanide donors + d2 acceptors = high SNR












